Ulka Vaishampayan, MBBS

Ulka Vaishampayan, MBBS

University of Michigan

Latest Content

Optimizing Sequential Therapy in Advanced RCC with expert team including Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Bradley McGregor, Dr. Rohit Gosain, and Dr. Rahul Gosain for oncology research and treatment advancements.

RCC

12/11/2025

Ep. 5: Optimizing Sequential Therapy in Advanced RCC

Bradley McGregor, MDUlka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Second-line RCC management, tolerability, comorbidities, long-term planning expert panel discussion at OncUpdates. Featuring Dr. Bradley McGregor, Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Rohit Gosain, and Dr. Rahul Gosain.

RCC

12/10/2025

Ep. 4: Second-Line RCC Management: Tolerability, Comorbidities, and Long-Term Planning

Ulka Vaishampayan, MBBSBradley McGregor, MDDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel discussion on balancing patient goals and efficacy in second-line RCC therapy featuring leading oncologists.

RCC

12/09/2025

Ep. 3: Balancing Patient Goals and Efficacy in Second-Line RCC Therapy

David Braun, MD, PhDUlka Vaishampayan, MBBSBradley McGregor, MDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates logo featuring expert healthcare professionals discussing Tivozanib in the current RCC treatment landscape, enhancing oncology and targeted therapy awareness.

RCC

12/07/2025

Ep. 1: Positioning Tivozanib in Today’s RCC Treatment Landscape

Ulka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel discussion on treating advanced renal cell carcinoma (RCC) after first-line therapy with leading oncologists.

RCC

12/06/2025

Treating Advanced RCC After First-Line Therapy (Full Video)

David Braun, MD, PhDBradley McGregor, MDUlka Vaishampayan, MBBSRahul Gosain, MD, MBARohit Gosain, MD